These results are consistent with a prior study of FcR-mediated effector function by an NTD-binding mAb [21] and further suggest that NTD-binding antibodies that display infection-enhancing properties in vitro also have the capacity to activate FcγRIIIa and may therefore have the potential to mediate ADCC. This evidence concerns the gene FCGR3A and infection.